Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Guided Therapeutics Inc.

Facebook Twitter LinkedIn Email Comments
Technology company Guided Therapeutics Inc. of Norcross, Ga., has completed an audit of its quality system to maintain ISO 13485 certification. This step is required to secure CE Marking for the sale of the company’s LuViva advanced cervical scan device in the European Union. Designed to provide instant results, the noninvasive diagnostic tool scans the cervix with light and uses spectroscopy for the early detection of disease. “Successfully completing these rigorous yearly audits shows that our processes and quality system are of the highest order,” said CEO Mark L. Faupel. The company submitted the CE Marking application in January; a 90-day review process was expected.


BioPhotonics
May 2012
AmericasBiophotonicsBusinesscervical cancer detectionGeorgiaGuided TherapeuticsGuided Therapeutics and CE MarkGuided Therapeutics and ISO 13485imagingindustrialLuVivaLuViva cervical scan deviceMark L. FaupelRapidScan

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.